Xiang Nan

Weihai 264209, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

AMPK inhibitor BML-275 induces neuroprotection through decreasing cyt c and AIF expression after transient brain ischemia.

AMPK inhibitor BML-275 induces neuroprotection through decreasing cyt c and AIF expression after transient brain ischemia.

Journal: Bioorganic & medicinal chemistry

Published: July 22, 2021

Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction.

Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction.

Journal: European journal of medicinal chemistry

Published: April 20, 2020

Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.

Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.

Journal: European journal of medicinal chemistry

Published: January 31, 2020

Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.

Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.

Journal: Cancer letters

Published: August 12, 2019

Design, synthesis and evaluation of sulfonylurea-containing 4-phenoxyquinolines as highly selective c-Met kinase inhibitors.

Design, synthesis and evaluation of sulfonylurea-containing 4-phenoxyquinolines as highly selective c-Met kinase inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: March 09, 2019

Development of an enzyme‑linked immunosorbent assay for camptothecin.

Development of an enzyme‑linked immunosorbent assay for camptothecin.

Journal: Molecular medicine reports

Published: November 08, 2018

Perspectives on biologically active camptothecin derivatives.

Perspectives on biologically active camptothecin derivatives.

Journal: Medicinal research reviews

Published: March 27, 2015

Synthesis of novel spin-labeled podophyllotoxin derivatives as potential antineoplastic agents: Part XXV.

Synthesis of novel spin-labeled podophyllotoxin derivatives as potential antineoplastic agents: Part XXV.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Published: February 25, 2015

Synthesis, biological activities and structure-activity relationships for new avermectin analogues.

Synthesis, biological activities and structure-activity relationships for new avermectin analogues.

Journal: European journal of medicinal chemistry

Published: August 22, 2014

Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.

Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.

Journal: Journal of medicinal chemistry

Published: July 09, 2014

Design, synthesis, crystal structure, insecticidal activity, molecular docking, and QSAR studies of novel N3-substituted imidacloprid derivatives.

Design, synthesis, crystal structure, insecticidal activity, molecular docking, and QSAR studies of novel N3-substituted imidacloprid derivatives.

Journal: Journal of agricultural and food chemistry

Published: May 20, 2014

Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Journal: Medicinal research reviews

Published: May 16, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026